Vascular Biogenics LTD. – Ordinary Shares (NASDAQ:VBLT) Shorted Shares Declined By 4.25%

May 3, 2018 - By Ira Colvard

Vascular Biogenics Ltd. (NASDAQ:VBLT) Corporate Logo

It was reported a decrease on Vascular Biogenics LTD. – Ordinary Shares (NASDAQ:VBLT)’s short interest with 4.25%. FINRA published in May VBLT’s total 623,700 short interest. That’s 4.25% down from 651,400 shares. Vascular Biogenics LTD. – Ordinary Shares (NASDAQ:VBLT) has 265,500 shares average volume. It’ll cost 2 days for VBLT to recover its former position. Float short on Vascular Biogenics LTD. – Ordinary Shares is 4.38%.

The last price was $2.2.Since May 3, 2017 it’s 59.29% down thus downtrending. The stock underperformed the S&P500 by 70.84%.

Vascular Biogenics Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for cancer.The company has $65.77 million market cap. The company??s program is based on its proprietary vascular targeting system platform technology, which utilizes genetically targeted therapy to destroy newly formed or angiogenic blood vessels.Last it reported negative earnings. The Company’s lead product candidate is VB-111, a gene biologic that is in Phase III clinical trials for the treatment of recurrent glioblastoma, an aggressive form of brain cancer; and has completed Phase II clinical trials for recurrent platinum-resistant ovarian cancer, as well as for iodine-resistant differentiated thyroid cancer.

Vascular Biogenics Ltd. (NASDAQ:VBLT) Ratings Coverage

A total of 4 analysts rate Vascular Biogenics (NASDAQ:VBLT) as follows: 0 “Buy”, 4 “Hold” and 0 “Sell”. Тherefore 0 are bullish. (NASDAQ:VBLT) has 6 ratings reports on May 3, 2018 according to StockzIntelligence. On Thursday, March 22 the firm has “Hold” rating by H.C. Wainwright given. On Thursday, March 8 the stock of Vascular Biogenics Ltd. (NASDAQ:VBLT) has “Hold” rating given by JMP Securities. On Friday, March 9 the stock has “Neutral” rating by Chardan Capital Markets. On Thursday, March 8 Piper Jaffray downgraded Vascular Biogenics Ltd. (NASDAQ:VBLT) to “Hold” rating. On Thursday, March 8 the firm earned “Neutral” rating by H.C. Wainwright. On Tuesday, November 7 the rating was maintained by H.C. Wainwright with “Buy”.

Vascular Biogenics Ltd. (NASDAQ:VBLT) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.